New Treatment Breakthrough for Asthma
This is a news story, published by Guardian, that relates primarily to Benralizumab news.
Benralizumab news
For more Benralizumab news, you can click here:
more Benralizumab newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
benralizumab injection. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Benralizumab news, severe asthma news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
asthma attacksGuardian
•Doctors hail first breakthrough in asthma and COPD treatment in 50 years
74% Informative
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils.
It is used as a repeat treatment for severe asthma at a low dose, but the trial found a higher dose could be very effective if injected at the time of flare-up.
Treatment for asthma and COPD exacerbations have not changed in 50 years , despite causing 3.8 m deaths worldwide a year combined.
VR Score
81
Informative language
85
Neutral language
49
Article tone
formal
Language
English
Language complexity
56
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links